anmelden
SMI Equal Weight
378,10
PKT
+0,04
PKT
+0,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.12 | Swiss Re buy | Vontobel Research | |
| 29.10.12 | UBS neutral | UBS AG | |
| 29.10.12 | UBS hold | Vontobel Research | |
| 29.10.12 | UBS neutral | Sarasin Research | |
| 29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 29.10.12 | Novartis outperform | Credit Suisse Group | |
| 26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 26.10.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Logitech neutral | UBS AG | |
| 26.10.12 | UBS neutral | Nomura | |
| 26.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | UBS neutral | Exane-BNP Paribas SA | |
| 26.10.12 | UBS equal-weight | Morgan Stanley | |
| 26.10.12 | Logitech hold | Vontobel Research | |
| 26.10.12 | Novartis reduce | Vontobel Research | |
| 26.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 25.10.12 | UBS hold | Vontobel Research | |
| 25.10.12 | Logitech neutral | Sarasin Research | |
| 25.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.10.12 | Novartis reduce | Vontobel Research | |
| 25.10.12 | Logitech hold | Vontobel Research | |
| 25.10.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 24.10.12 | Novartis underperform | Cheuvreux SA | |
| 24.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 23.10.12 | Swiss Re neutral | Credit Suisse Group | |
| 23.10.12 | Holcim overweight | HSBC | |
| 23.10.12 | Holcim overweight | HSBC | |
| 23.10.12 | Holcim neutral | Credit Suisse Group | |
| 23.10.12 | UBS hold | Commerzbank Corp. & Markets | |
| 23.10.12 | Holcim outperform | Credit Suisse Group | |
| 23.10.12 | Nestlé overweight | J.P. Morgan Cazenove | |
| 23.10.12 | Novartis buy | Nomura |